Migration and remyelination by oligodendrocyte progenitor cells transplanted adjacent to focal areas of spinal cord inflammation

Journal of Neuroscience Research

Volumn 89, Issue 11, 2011, Pages 1737-1746

  Wang, Yanping ^a   Piao, Jing Hua ^a   Larsen, Eric C ^a   Kondo, Yoichi ^a   Duncan, Ian D ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Demyelination; Multiple sclerosis; Toll like receptor; Zymosan

Indexed keywords

GREEN FLUORESCENT PROTEIN;

ADOLESCENT; ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTOSIS; CELL DIFFERENTIATION; CELL MIGRATION; CELL TRANSPLANTATION; CONTROLLED STUDY; DEMYELINATION; FEMALE; MACROPHAGE ACTIVATION; MULTIPLE SCLEROSIS; MYELITIS; NERVE FIBER DEGENERATION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; RAT; REMYELINIZATION; STEM CELL;

ANIMALS; CELL DIFFERENTIATION; CELL MOVEMENT; DEMYELINATING DISEASES; FEMALE; MYELIN SHEATH; MYELITIS; NEURAL STEM CELLS; OLIGODENDROGLIA; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD;

EID: 80052646657     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22716     Document Type: Article

References (43)

1. Aharonowiz M, Einstein O, Fainstein N, Lassmann H, Reubinoff B, Ben-Hur T. 2008. Neuroprotective effect of transplanted human embryonic stem cell-derived neural precursors in an animal model of multiple sclerosis. PLoS One 3: e3145.
2. Archer DR, Cuddon PA, Lipsitz D, Duncan ID. 1997. Myelination of the canine central nervous system by glial cell transplantation: a model for repair of human myelin disease. Nat Med 3: 54-59.
3. Asakura K, Hunter SF, Rodriguez M. 1997. Effects of transforming growth factor-beta and platelet-derived growth factor on oligodendrocyte precursors: insights gained from a neuronal cell line. J Neurochem 68: 2281-2290.
4. Bartnik BL, Juurlink BH, Devon RM. 2000. Macrophages: their myelinotrophic or neurotoxic actions depend upon tissue oxidative stress. Mult Scler 6: 37-42.
5. Ben-Hur T, Goldman SA. 2008. Prospects of cell therapy for disorders of myelin. Ann N Y Acad Sci 1142: 218-249.
6. Blakemore WF, Irvine KA. 2008. Endogenous or exogenous oligodendrocytes for remyelination. J Neurol Sci 265: 43-46.
7. Blakemore WF, Crang AJ, Franklin RJM, Ransom BR, Kettenmann H. 1995. Transplantation of glial cells. Neuroglial cells. New York: Oxford University Press. p 869-882.
8. Compston A, McDonald I, Noseworthy J, Lassmann H, Miller D, Smith K, Wekerle H, Confavreux C. 2006. McAlpine's multiple sclerosis. New York: Churchill Livingstone Elsevier. 1008 p.
9. Copelman CA, Cuzner ML, Groome N, Diemel LT. 2000. Temporal analysis of growth factor mRNA expression in myelinating rat brain aggregate cultures: increments in CNTF, FGF-2, IGF-I, and PDGF-AA mRNA are induced by antibody-mediated demyelination. Glia 30: 342-351.
10. Diemel LT, Jackson SJ, Cuzner ML. 2003. Role for TGF-beta1, FGF-2 and PDGF-AA in a myelination of CNS aggregate cultures enriched with macrophages. J Neurosci Res 74: 858-867.
11. Dubois-Dalcq M, ffrench-Constant C, Franklin RJM. 2005. Enhancing central nervous system remyelination in multiple sclerosis. Neuron 48: 9-12.
12. Duncan ID. 2008. Replacing cells in multiple sclerosis. J Neurol Sci 265: 89-92.
13. Einstein O, Karussis D, Grigoriadis N, Mizrachi-Kol R, Reinhartz E, Abramsky O, Ben-Hur T. 2003. Intraventricular transplantation of neural precursor cell spheres attenuates acute experimental allergic encephalomyelitis. Mol Cell Neurosci 24: 1074-1082.
14. Einstein O, Grigoriadis N, Mizrachi-Kol R, Reinhartz E, Polyzoidou E, Lavon I, Milonas I, Karussis D, Abramsky O, Ben-Hur T. 2006. Transplanted neural precursor cells reduce brain inflammation to attenuate chronic experimental autoimmune encephalomyelitis. Exp Neurol 198: 275-284.
15. Einstein O, Fainstein N, Vaknin I, Mizrachi-Kol R, Reihartz E, Grigoriadis N, Lavon I, Baniyash M, Lassmann H, Ben-Hur T. 2007. Neural precursors attenuate autoimmune encephalomyelitis by peripheral immunosuppression. Ann Neurol 61: 209-218.
16. Einstein O, Friedman-Levi Y, Grigoriadis N, Ben-Hur T. 2009. Transplanted neural precursors enhance host brain-derived myelin regeneration. J Neurosci 29: 15694-15702.
17. Farez MF, Quintana FJ, Gandhi R, Izquierdo G, Lucas M, Weiner HL. 2009. Toll-like receptor 2 and poly(ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE. Nat Immunol 10: 958-964.
18. Franklin RJ. 2002. Why does remyelination fail in multiple sclerosis? Nat Rev Neurosci 3: 705-714.
19. Franklin RJ, ffrench-Constant C. 2008. Remyelination in the CNS: from biology to therapy. Nat Rev Neurosci 9: 839-855.
20. Franklin RJ, Bayley SA, Blakemore WF. 1996. Transplanted CG4 cells (an oligodendrocyte progenitor cell line) survive, migrate, and contribute to repair of areas of demyelination in X-irradiated and damaged spinal cord but not in normal spinal cord. Exp Neurol 137: 263-276.
21. Gensert JM, Goldman JE. 1997. Endogenous progenitors remyelinate demyelinated axons in the adult CNS. Neuron 19: 197-203.
22. Hatch MN, Schaumburg CS, Lane TE, Keirstead HS. 2009. Endogenous remyelination is induced by transplant rejection in a viral model of multiple sclerosis. J Neuroimmunol 212: 74-81.
23. Hinks GL, Franklin RJ. 1999. Distinctive patterns of PDGF-A, FGF-2, IGF-I, and TGF-beta1 gene expression during remyelination of experimentally-induced spinal cord demyelination. Mol Cell Neurosci 14: 153-168.
24. H1 response to cutaneous sensitization. J Allergy Clin Immunol 123: 875-882.
25. Kassis I, Grigoriadis N, Gowda-Kurkalli B, Mizrachi-Kol R, Ben-Hur T, Slavin S, Abramsky O, Karussis D. 2008. Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis. Arch Neurol 65: 753-761.
26. Kondo Y, Wenger DA, Gallo V, Duncan ID. 2005. Galactocerebrosidase-deficient oligodendrocytes maintain stable central myelin by exogenous replacement of the missing enzyme in mice. Proc Natl Acad Sci U S A 102: 18670-18675.
27. Lachapelle F, Avellana-Adalid V, Nait-Oumesmar B, Baron-Van Evercooren A. 2002. Fibroblast growth factor-2 (FGF-2) and platelet-derived growth factor AB (PDGF AB) promote adult SVZ-derived oligodendrogenesis in vivo. Mol Cell Neurosci 20: 390-403.
28. Louis JC, Magal E, Muir D, Manthorpe M, Varon S. 1992. CG-4, a new bipotential glial cell line from rat brain, is capable of differentiating in vitro into either mature oligodendrocytes or type-2 astrocytes. J Neurosci Res 31: 193-204.
29. Milward EA, Zhang SC, Zhao M, Lundberg C, Ge B, Goetz BD, Duncan ID. 2000. Enhanced proliferation and directed migration of oligodendroglial progenitors co-grafted with growth factor-secreting cells. Glia 32: 264-270.
30. Mothe AJ, Tator CH. 2008. Transplanted neural stem/progenitor cells generate myelinating oligodendrocytes and Schwann cells in spinal cord demyelination and dysmyelination. Exp Neurol 213: 176-190.
31. O'Leary MT, Blakemore WF. 1997. Oligodendrocyte precursors survive poorly and do not migrate following transplantation into the normal adult central nervous system. J Neurosci Res 48: 159-167.
32. Owens T. 2009. Toll-like receptors in neurodegeneration. Curr Top Microbiol Immunol 336: 105-120.
33. Peress NS, Perillo E, Seidman RJ. 1996. Glial transforming growth factor (TGF)-beta isotypes in multiple sclerosis: differential glial expression of TGF-β1, 2 and 3 isotypes in multiple sclerosis. J Neuroimmunol 71: 115-123.
34. Pluchino S, Quattrini A, Brambilla E, Gritti A, Salani G, Dina G, Galli R, Del Carro U, Amadio S, Bergami A, Furlan R, Comi G, Vescovi AL, Martino G. 2003. Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature 422: 688-694.
35. Pluchino S, Zanotti L, Rossi B, Brambilla E, Ottoboni L, Salani G, Martinello M, Cattalini A, Bergami A, Furlan R, Comi G, Constantin G, Martino G. 2005. Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. Nature 436: 266-271.
36. Popovich PG, Guan Z, McGaughy V, Fisher L, Hickey WF, Basso DM. 2002. The neuropathological and behavioral consequences of intraspinal microglial/macrophage activation. J Neuropathol Exp Neurol 61: 623-633.
37. Schonberg DL, Popovich PG, McTigue DM. 2007. Oligodendrocyte generation is differentially influenced by toll-like receptor (TLR) 2 and TLR4-mediated intraspinal macrophage activation. J Neuropathol Exp Neurol 66: 1124-1135.
38. Setzu A, Lathia JD, Zhao C, Wells K, Rao MS, Ffrench-Constant C, Franklin RJ. 2006. Inflammation stimulates myelination by transplanted oligodendrocyte precursor cells. Glia 54: 297-303.
39. Tontsch U, Archer DR, Dubois-Dalcq M, Duncan ID. 1994. Transplantation of an oligodendrocyte cell line leading to extensive myelination. Proc Natl Acad Sci U S A 91: 11616-11620.
40. Tourbah A, Linnington C, Bachelin C, Avellana-Adalid V, Wekerle H, Baron-Van Evercooren A. 1997. Inflammation promotes survival and migration of the CG4 oligodendrocyte progenitors transplanted in the spinal cord of both inflammatory and demyelinated EAE rats. J Neurosci Res 50: 853-861.
41. Veldhoen M, Hocking RJ, Flavell RA, Stockinger B. 2006. Signals mediated by transforming growth factor-beta initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease. Nat Immunol 7: 1151-1156.
42. Windrem MS, Schanz SJ, Guo M, Tian GF, Washco V, Stanwood N, Rasband M, Roy NS, Nedergaard M, Havton LA, Wang S, Goldman SA. 2008. Neonatal chimerization with human glial progenitor cells can both remyelinate and rescue the otherwise lethally hypomyelinated shiverer mouse. Cell Stem Cell 2: 553-565.
43. Zhang Y, Taveggia C, Melendez-Vasquez C, Einheber S, Raine CS, Salzer JL, Brosnan CF, John GR. 2006. Interleukin-11 potentiates oligodendrocyte survival and maturation, and myelin formation. J Neurosci 26: 12174-12185.